Evidence map›Paper›PMID 36202870›Full record

ArticleNature communications2022

Loss of Zfp335 triggers cGAS/STING-dependent apoptosis of post-β selection thymocytes.

Jeremy J Ratiu, William E Barclay, Elliot Lin, Qun Wang, Sebastian Wellford, Naren Mehta, Melissa J Harnois, Devon DiPalma, Sumedha Roy, Alejandra V Contreras and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Jeremy J RatiuDuke University, Department of Immunology, Durham, NC, 27710, USA. Jeremy.Ratiu@duke.edu.ORCID 0000-0001-9234-7674
William E BarclayDuke University, Department of Immunology, Durham, NC, 27710, USA.
Elliot LinDuke University, Department of Immunology, Durham, NC, 27710, USA.ORCID 0000-0001-5512-7998
Qun WangDuke University, Department of Immunology, Durham, NC, 27710, USA.
Sebastian WellfordDuke University, Department of Immunology, Durham, NC, 27710, USA.ORCID 0000-0002-2535-6893
Naren MehtaDuke University, Department of Immunology, Durham, NC, 27710, USA.ORCID 0000-0003-0829-3592
Melissa J HarnoisDuke University, Department of Immunology, Durham, NC, 27710, USA.ORCID 0000-0002-5910-6198
Devon DiPalmaDuke University, Department of Immunology, Durham, NC, 27710, USA.ORCID 0000-0003-0603-3084
Sumedha RoyDuke University, Department of Immunology, Durham, NC, 27710, USA.
Alejandra V ContrerasFox Chase Cancer Center, Blood Cell Development and Function Program, Philadelphia, PA, 19111, USA.
Mari L ShinoharaDuke University, Department of Immunology, Durham, NC, 27710, USA.ORCID 0000-0002-6808-9844
David WiestFox Chase Cancer Center, Blood Cell Development and Function Program, Philadelphia, PA, 19111, USA.ORCID 0000-0002-0792-3188
Yuan ZhuangDuke University, Department of Immunology, Durham, NC, 27710, USA.
Duke University · USFox Chase Cancer Center · US

Funding

The role of TCR, ligand, and signal strength in human γδ T cell developmentP01AI102853 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI Maria Ciofani · 2014 to 2026
$26.3M
HEB MEDIATED PATHWAYS AND FUNCTION IN T CELL DEVELOPMENTR01GM059638 · NIGMS · DUKE UNIVERSITY · PI CHAN, FRANCIS KAMING · 1999 to 2021
$6.9M
Medical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
$6.6M
Basic Immunology Training ProgramT32AI052077 · NIAID · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2002 to 2024
$4.2M
Heterogeneous immune responses of the alveolar macrophage population during pulmonary fungal infectionsR01AI160737 · NIAID · DUKE UNIVERSITY · PI SHINOHARA, MARI L. · 2021 to 2025
$2.7M
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational AttenuationR01AI099100 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI DUPREX, WILLIAM PAUL · 2013 to 2017
$2.0M
Protective role of Clec7a/dectin-1 in CNS autoimmunityR01NS120417 · NINDS · DUKE UNIVERSITY · PI SHINOHARA, MARI L. · 2021 to 2025
$2.0M
NIAID NIH HHS P01 AI102853NIAID NIH HHS R01 AI099100NIAID NIH HHS R01 AI160737NIAID NIH HHS T32 AI052077NIGMS NIH HHS R01 GM059638NIGMS NIH HHS T32 GM145449NINDS NIH HHS R01 NS120417
6 · The paper itself

Abstract

Production of a functional peripheral T cell compartment typically involves massive expansion of the bone marrow progenitors that seed the thymus. There are two main phases of expansion during T cell development, following T lineage commitment of double-negative (DN) 2 cells and after successful rearrangement and selection for functional TCRβ chains in DN3 thymocytes, which promotes the transition of DN4 cells to the DP stage. The signals driving the expansion of DN2 thymocytes are well studied. However, factors regulating the proliferation and survival of DN4 cells remain poorly understood. Here, we uncover an unexpected link between the transcription factor Zfp335 and control of cGAS/STING-dependent cell death in post-β-selection DN4 thymocytes. Zfp335 controls survival by sustaining expression of Ankle2, which suppresses cGAS/STING-dependent cell death. Together, this study identifies Zfp335 as a key transcription factor regulating the survival of proliferating post-β-selection thymocytes and demonstrates a key role for the cGAS/STING pathway in driving apoptosis of developing T cells.

Indexed as

ApoptosisThymocytesAnimalsCell DifferentiationMembrane ProteinsMiceMice, Inbred C57BLNucleotidyltransferasesThymus GlandTranscription FactorsMembrane ProteinsNucleotidyltransferasesTranscription Factors

Identifiers

PMID36202870
PMCPMC9537144
OpenAlexW4302425050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.